TY  - CHAP
M1  - Book, Section
TI  - Chapter 16. Pharmacogenomics in Neurology
A1  - Gengo, Francis M.
A1  - Rainka, Michelle M.
A2  - Bertino, Joseph S.
A2  - DeVane, C. Lindsay
A2  - Fuhr, Uwe
A2  - Kashuba, Angela D.
A2  - Ma, Joseph D.
PY  - 2013
T2  - Pharmacogenomics: An Introduction and Clinical Perspective
AB  - Review  specific  neurological  disease  states  and  the  pharmacogenomics  of  these.Discuss  how  pharmacogenomics  affects  response  to  drug  therapy  and  its  implications.Outline  how  pharmacogenomics  and  pharmacogenomic  testing  will  have  an  impact  on  diagnosis  and  treatment  of  neurological  disease  states.  
SN  - 
PB  - The McGraw-Hill Companies
CY  - New York, NY
Y2  - 2024/04/19
UR  - accesspharmacy.mhmedical.com/content.aspx?aid=56877720
ER  -